Viasana, UAB - financials and debts

Company age: 20 y. 10 mo.

Update

Viasana - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 8,834,704 11,726,218 13,035,448 16,597,056 17,010,946 17,800,398 18,022,579 19,118,651
Profit before tax 1,246,085 1,832,042 1,967,110 1,834,212 2,305,462 3,130,928 2,397,709 2,497,095
Net profit 1,071,860 1,578,642 1,683,336 1,562,358 1,963,240 2,661,158 2,038,876 2,099,836
Equity 2,347,772 2,926,415 4,209,751 4,872,109 6,585,349 8,646,507 10,335,383 11,835,219
Liabilities 2,575,478 3,081,624 2,975,226 2,551,874 5,059,718 5,936,880 3,592,704 3,373,121
Non-current assets 2,644,735 3,150,817 3,173,462 3,385,622 9,845,998 10,693,364 11,117,534 11,667,811
Current assets 2,276,953 2,855,852 4,008,487 4,035,756 1,795,993 3,882,592 2,804,597 3,537,074
Total assets 4,921,688 6,006,669 7,181,949 7,421,378 11,641,991 14,575,956 13,922,131 15,204,885
Taxes paid
STI taxes - - - - - 755,761 925,343 896,520
Social insurance contributions - - - - - 81,094 122,194 110,776
Financial indicators
Revenue change y/y +32.6% +32.7% +11.2% +27.3% +2.5% +4.6% +1.2% +6.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 21.8% 26.3% 23.4% 21.1% 16.9% 18.3% 14.6% 13.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 45.7% 53.9% 40.0% 32.1% 29.8% 30.8% 19.7% 17.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 12.1% 13.5% 12.9% 9.4% 11.5% 14.9% 11.3% 11.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 14.1% 15.6% 15.1% 11.1% 13.6% 17.6% 13.3% 13.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.1 1.1 0.7 0.5 0.8 0.7 0.3 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 1,262,101 1,529,500 1,475,717 1,373,553 1,300,203 1,643,119 1,501,882 1,593,221

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Viasana - Social security debts

From To Debt, €
2025-06-17 2025-06-19 0.14
2025-04-24 2025-04-29 0.14
2025-01-16 2025-01-19 103.01
2023-04-18 2023-04-20 39.64

Viasana - VMI tax arrears

From To Overdue, €
2026-03-29 2026-04-02 6.33
2026-03-27 2026-03-28 6.57
2026-03-24 2026-03-26 185.08
2026-03-20 2026-03-23 101669.0
2026-03-19 2026-03-19 89754.0
2025-01-14 2025-01-15 259.77

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Viasana, UAB (code 300155391) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €19.12M and net profit of €2.10M, corresponding to a profit margin of 11.0%. Revenue increased by 6.1% year on year and by 7.4% over two years, reflecting steady top-line growth. Over the 2023–2025 period, revenue rose from €17.80M to €18.02M and then to €19.12M, while net profit moved from €2.66M to €2.04M and then to €2.10M. Profitability therefore remained solid, although the margin declined from 14.9% in 2023 to 11.3% in 2024 and 11.0% in 2025. At the end of 2025, total assets were €15.20M, equity €11.84M and liabilities €3.37M, with an equity ratio of 77.8% and debt-to-equity of 0.29. Asset turnover was 1.26x, ROE 17.7% and ROA 13.8%. Revenue per employee was €1.59M.